{"organizations": [], "uuid": "60d648b8a98ce586269b832041708cb7dde78d10", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-arrowhead-pharmaceuticals-announce/brief-arrowhead-pharmaceuticals-announces-pricing-of-underwritten-public-offering-of-common-stock-idUSASB0C1FL", "country": "US", "domain_rank": 408, "title": "BRIEF-Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T16:07:00.000+02:00", "replies_count": 0, "uuid": "60d648b8a98ce586269b832041708cb7dde78d10"}, "author": "", "url": "https://www.reuters.com/article/brief-arrowhead-pharmaceuticals-announce/brief-arrowhead-pharmaceuticals-announces-pricing-of-underwritten-public-offering-of-common-stock-idUSASB0C1FL", "ord_in_thread": 0, "title": "BRIEF-Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-arrowhead pharmaceuticals announces pricing of underwritten public offering of common stock", "sentiment": "negative"}, {"name": "public offering of common stock reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "arrowhead pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 18, 2018 / 2:08 PM / in 11 minutes BRIEF-Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock Reuters Staff \nJan 18 (Reuters) - Arrowhead Pharmaceuticals Inc: \n* ARROWHEAD PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK \n* SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $5.25PER SHARE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-18T16:07:00.000+02:00", "crawled": "2018-01-18T16:22:36.000+02:00", "highlightTitle": ""}